Barrington raised the firm’s price target on HealthEquity to $85 from $80 and keeps an Outperform rating on the shares. The company recently reported Q2 results that came in “above expectations,” the analyst tells investors. Its revenue and EPS beat consensus estimates and the company also raised it FY24 guidance, the firm says. Barrington expects operation and financial performance to continue to improve on a consolidated basis.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity raises FY24 EPS view to $1.97-$2.06 from $1.88-$1.97
- HealthEquity Reports Second Quarter Ended July 31, 2023 Financial Results
- HealthEquity reports Q2 EPS 53c, consensus 48c
- Options Volatility and Implied Earnings Moves Today, September 05, 2023
- Options Volatility and Implied Earnings Moves This Week, September 05 – September 08, 2023
Questions or Comments about the article? Write to editor@tipranks.com